Latest news
Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 04:31:46 GMTNew drug delivers promising survival gains in pancreatic cancer - News-MedicalNews-Medical · Mon, 10 Aug 2026 03:11:00 GMTHeghine Khachatryan: Rethinking VTE Risk Assessment in Hospitalized Cancer Patients - OncodailyOncodaily · Sun, 09 Aug 2026 18:39:22 GMTMorning Immunotherapy May Improve Survival Outcomes in Advanced Cancer Patients: Meta-Analysis Finds - Medical DialoguesMedical Dialogues · Sun, 09 Aug 2026 15:45:38 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago TribuneChicago Tribune · Sun, 09 Aug 2026 11:00:17 GMTInnovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer - biopharmaapac.combiopharmaapac.com · Sat, 08 Aug 2026 16:11:09 GMTShe faced cancer for decades. Now, she wants to ‘enjoy every minute.’ - Oshkosh NorthwesternOshkosh Northwestern · Sat, 08 Aug 2026 09:55:00 GMTScientists identify which cancer patients would respond well to glaucoma drugs - The Institute of Cancer Research (ICR)The Institute of Cancer Research (ICR) · Sat, 08 Aug 2026 07:45:26 GMT